Entrada Therapeutics, Inc. (TRDA) stock
TRDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.17−0.27 (-4.96%)
Close on Nov 12, 2026Market cap $201.30MP/E –Yield –
Entrada Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Entrada Therapeutics's enterprise value was -$11.18M on Nov 11, 2026, against $65.71M a year earlier. Over the last 5 years it ranged from -$159.40M to $468.67M, with a median of $110.43M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$11.18M | -116.9% |
| 2025 | Dec 31, 2025 | $66.09M | -66.5% |
| 2024 | Dec 31, 2024 | $197.35M | +32.0% |
| 2023 | Dec 29, 2023 | $149.50M | -28.1% |
| 2022 | Dec 30, 2022 | $207.92M | – |
| 2021 | Dec 31, 2021 | -$95.67M | – |
See a number that looks wrong?